戻る
Biostem Technologies Inc (BSEM)価格
BSEM 株価推移チャート
BSEM 財務
Biostem Technologies Inc
$5.8
5.07%
$0.28
終値： Feb 13, 16:00:00 GMT-5
$5.8
0%
$0
アフターマーケット：Feb 13, 20:00:00 GMT-5
収入
貸借対照表
現金の流れ
年次
四半期
BSEM 収入
金額は百万米ドル単位。会計年度は2月から1月まで。
Follow-Up Questions
Biostem Technologies Incの主要な財務諸表は何ですか？
BSEMの主要な財務比率は何ですか？
Biostem Technologies Incの収益はセグメントまたは地域別にどのように分けられていますか？
Biostem Technologies Incは収益を上げていますか？
Biostem Technologies Incに負債はありますか？
Biostem Technologies Incの発行済株式数は何株ですか？
主要データ
前終値
$5.52
始値
$5.66
当日レンジ
$5.6 - $5.85
52週レンジ
$3.09 - $15.74
取引高
14.8K
平均取引高
112.1K
1株当たり利益(TTM)
1.19
配当利回り
--
時価総額
$97.3M
BSEMとは何ですか？
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. The company is headquartered in Pompano Beach, Florida. The company went IPO on 2001-07-11. Leveraging its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. Its products include VENDAJE, VENDAJE AC, VENDAJE OPTIC and AmnioWrap2. VENDAJE is a structural tissue allograft composed of the amnion layer of the placental membrane. VENDAJE is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE AC is a thicker structural tissue allograft composed of the amnion and chorion layer of the placental membrane. VENDAJE AC is intended for homologous use as a protective covering for soft tissue wounds. VENDAJE OPTIC is a structural tissue allograft composed of the amnion layer of the placental membrane. AmnioWrap2 is a placental-based allograft comprised of unseparated amnion and chorion membranes, including the intact intermediate layer.